Aaron Hudson

Aaron Hudson is a seasoned professional in the life sciences and diagnostics industries, currently serving as the Acquisition Transition Leader at Danaher Corporation, where responsibilities include managing the $5.7 billion acquisition of Abcam. Prior to this role, Aaron spent over a decade at SCIEX, holding key positions such as Vice President Strategy and Vice President of Global Marketing & Strategy, leading teams to drive profitable growth in precision medicine and diagnostics. Earlier experience includes strategic marketing and sales in mass spectrometry at Applied Biosystems and Waters (Micromass), with foundational expertise developed through a PhD in Molecular Genetics and a BSc in Biochemistry from The University of Sheffield.